Copertina

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yaping Zhan, Shu Lin, Lingjie Lin, Min Lin, Yi Wang, Shihui Bao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
di: Eugene Jeong, et al.
Pubblicazione: (2025)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
di: Youjun Chen, et al.
Pubblicazione: (2025)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
di: William L. Baker, et al.
Pubblicazione: (2026)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
di: Lena Makortoff, et al.
Pubblicazione: (2024)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
di: Amy Broadwater, et al.
Pubblicazione: (2026)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
di: Majid Khalilizad, et al.
Pubblicazione: (2025)

Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”
di: Keisuke Mine, et al.
Pubblicazione: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
di: Amira R. Rashdan, et al.
Pubblicazione: (2026)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
di: Sandra L. Kane‐Gill
Pubblicazione: (2025)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
di: Alfred Zheng Ting Ho, et al.
Pubblicazione: (2026)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
di: Wenqiang Zhou, et al.
Pubblicazione: (2026)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)

Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence
di: Meng‐Fei Dai, et al.
Pubblicazione: (2025)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
di: Jyotirmoy Sarker, et al.
Pubblicazione: (2024)

Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study
di: Arden R. Barry, et al.
Pubblicazione: (2025)

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
di: Saurabh Rahurkar, et al.
Pubblicazione: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Pubblicazione: (2025)

Enhancing thromboprophylaxis after colorectal cancer surgery in China: Bridging the gap between evidence and implementation through pathway optimization
di: Zhi‐Chun Gu, et al.
Pubblicazione: (2024)

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study
di: Grace Hsin‐Min Wang, et al.
Pubblicazione: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
di: Trisha Matsuura, et al.
Pubblicazione: (2025)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
di: Kathleen A. Stringer, et al.
Pubblicazione: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
di: Shibing Tao, et al.
Pubblicazione: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
di: Ashlan J. Kunz Coyne, et al.
Pubblicazione: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
di: Jennifer N. Clements, et al.
Pubblicazione: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
di: Susan E. Smith, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)